Moreover, our molecular docking study revealed robust interactions of BC-N102 with CDK2 and CDK4 binding cavities with binding affinities (ΔG) of -9.7 and -6.9 kcal/mol respectively. The gene discussed is CDK2; the disease is breast cancer.